NASDAQ:MDRX - Allscripts Stock Price, Price Target & More

$12.23 -0.09 (-0.73 %)
(As of 04/24/2018 08:36 AM ET)
Previous Close$12.32
Today's Range$12.19 - $12.46
52-Week Range$10.78 - $16.13
Volume709,300 shs
Average Volume1.94 million shs
Market Capitalization$2.19 billion
P/E Ratio26.02
Dividend YieldN/A
Beta1.23

About Allscripts (NASDAQ:MDRX)

Allscripts logoAllscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company's Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company's Netsmart segment operates in and provides software and technology solutions to the health and human services, and post-acute sectors of health care. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
SymbolNASDAQ:MDRX
CUSIP01988P10
Phone312-506-1200

Debt

Debt-to-Equity Ratio1.33%
Current Ratio0.97%
Quick Ratio0.97%

Price-To-Earnings

Trailing P/E Ratio26.02
Forward P/E Ratio21.84
P/E Growth1.59

Sales & Book Value

Annual Sales$1.81 billion
Price / Sales1.20
Cash Flow$1.6708 per share
Price / Cash7.32
Book Value$6.42 per share
Price / Book1.90

Profitability

EPS (Most Recent Fiscal Year)$0.47
Net Income$-152,600,000.00
Net Margins-10.88%
Return on Equity7.36%
Return on Assets2.19%

Miscellaneous

Employees8,900
Outstanding Shares177,950,000

How to Become a New Pot Stock Millionaire

Allscripts (NASDAQ:MDRX) Frequently Asked Questions

What is Allscripts' stock symbol?

Allscripts trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts' earnings last quarter?

Allscripts (NASDAQ:MDRX) issued its earnings results on Thursday, February, 15th. The software maker reported $0.18 earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of $0.18. The software maker had revenue of $547 million for the quarter, compared to analysts' expectations of $524.05 million. Allscripts had a positive return on equity of 7.36% and a negative net margin of 10.88%. The company's revenue was up 27.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.14 earnings per share. View Allscripts' Earnings History.

When is Allscripts' next earnings date?

Allscripts is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Allscripts.

What guidance has Allscripts issued on next quarter's earnings?

Allscripts issued an update on its FY18 earnings guidance on Thursday, February, 15th. The company provided EPS guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.79. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.15 billion.

What price target have analysts set for MDRX?

17 brokerages have issued twelve-month target prices for Allscripts' stock. Their predictions range from $12.00 to $20.00. On average, they anticipate Allscripts' share price to reach $16.3438 in the next year. View Analyst Ratings for Allscripts.

What are Wall Street analysts saying about Allscripts stock?

Here are some recent quotes from research analysts about Allscripts stock:
  • 1. Cantor Fitzgerald analysts commented, "Today, MDRX filed an 8-K indicating that Netsmart has acquired the homecare software business from Change Healthcare for $167.5 million." (4/5/2018)
  • 2. According to Zacks Investment Research, "Allscripts has had a favorable run on the bourses over the last year, trading above the broader industry. The company’s solid growth in U.S. Core Solutions and Services holds promise at the moment. Allscripts Sunrise electronic health record (EHR) platform and Revenue Cycle Management Services are likely to drive the company’s top line in the quarters to come. Also, Allscripts has a leading market share in inpatient and ambulatory settings. Allscripts announced a definitive agreement to buy Practice Fusion for $100 million in cash. However, the company’s continued reliance on mergers and acquisition activities poses substantial integration risks. Intensifying competition is a major dampener. The company’s products have a long sales cycle which involves intensive decision-making at different managerial levels. Allscripts also expects a modest increase in operating expenses to support business growth over the long haul." (1/25/2018)
  • 3. Maxim Group analysts commented, "MDRX announced the acquisition of Practice Fusion, a provider of cloud- based electronic health record (EHR) platforms, for $100M in cash. The acquisition is expected to close in 1Q18. We believe Practice Fusion was sold at 1.0x-2.0x revenue, implying a $50M- $100M revenue run rate. It is expected to be marginally accretive in 2018. We estimate that the company’s recently-acquired Enterprise Information Systems (EIS) business is operating at a roughly $400M-$450M revenue run rate, significantly above our original estimate of $300M. We believe attrition in the EIS business may be lower than originally projected." (1/9/2018)

Are investors shorting Allscripts?

Allscripts saw a increase in short interest in March. As of March 29th, there was short interest totalling 17,204,055 shares, an increase of 29.0% from the March 15th total of 13,337,504 shares. Based on an average daily trading volume, of 1,946,518 shares, the short-interest ratio is currently 8.8 days. Currently, 9.7% of the shares of the company are sold short.

Who are some of Allscripts' key competitors?

Who are Allscripts' key executives?

Allscripts' management team includes the folowing people:
  • Mr. Paul M. Black, CEO & Director (Age 60)
  • Mr. Richard J. Poulton, Pres (Age 53)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 55)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel & Chief Admin. Officer (Age 48)
  • Mr. James R. Hewitt, Exec. VP, Solutions Devel. (Age 51)

Has Allscripts been receiving favorable news coverage?

News headlines about MDRX stock have trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Allscripts earned a media sentiment score of 0.13 on Accern's scale. They also gave media coverage about the software maker an impact score of 49.30 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Allscripts?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts' stock price today?

One share of MDRX stock can currently be purchased for approximately $12.23.

How big of a company is Allscripts?

Allscripts has a market capitalization of $2.19 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts employs 8,900 workers across the globe.

How can I contact Allscripts?

Allscripts' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]


MarketBeat Community Rating for Allscripts (MDRX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  476 (Vote Outperform)
Underperform Votes:  472 (Vote Underperform)
Total Votes:  948
MarketBeat's community ratings are surveys of what our community members think about Allscripts and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Allscripts (NASDAQ:MDRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Allscripts in the last 12 months. Their average twelve-month price target is $16.3438, suggesting that the stock has a possible upside of 33.64%. The high price target for MDRX is $20.00 and the low price target for MDRX is $12.00. There are currently 1 sell rating, 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.652.632.562.56
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $16.3438$16.3667$15.7667$15.00
Price Target Upside: 33.64% upside14.53% upside3.05% upside8.54% upside

Allscripts (NASDAQ:MDRX) Consensus Price Target History

Price Target History for Allscripts (NASDAQ:MDRX)

Allscripts (NASDAQ:MDRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/24/2018JPMorgan ChaseInitiated CoverageBuy$16.00LowView Rating Details
4/5/2018Cantor FitzgeraldReiterated RatingBuy$18.00LowView Rating Details
2/27/2018Bank of AmericaInitiated CoverageBuy -> Buy$17.00LowView Rating Details
2/17/2018Wells FargoSet Price TargetBuy$19.00HighView Rating Details
1/18/2018Evercore ISIInitiated CoverageOutperform -> Outperform$17.50MediumView Rating Details
1/16/2018SunTrust BanksDowngradeBuy -> HoldHighView Rating Details
1/11/2018Royal Bank of CanadaSet Price TargetBuy$19.00HighView Rating Details
1/9/2018Maxim GroupReiterated RatingBuy$20.00MediumView Rating Details
1/4/2018CitigroupInitiated CoverageBuyLowView Rating Details
11/3/2017Robert W. BairdBoost Price TargetOutperform$16.00 -> $17.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 -> $16.00LowView Rating Details
9/11/2017CowenUpgradeMarket Perform -> Outperform$13.00 -> $16.00HighView Rating Details
8/25/2017Jefferies GroupSet Price TargetBuy$17.00LowView Rating Details
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 -> $12.00LowView Rating Details
7/21/2017Piper JaffrayReiterated RatingHold$14.00LowView Rating Details
6/19/2017Leerink SwannDowngradeOutperform -> Market Perform$15.00 -> $13.00MediumView Rating Details
3/24/2017Deutsche BankUpgradeHold -> Buy$12.50 -> $14.00LowView Rating Details
2/17/2017OppenheimerReiterated RatingHoldN/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
10/5/2016UBSInitiated CoverageBuy$17.00N/AView Rating Details
8/5/2016Goldman SachsBoost Price TargetNeutral$14.00 -> $16.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

Allscripts (NASDAQ:MDRX) Earnings History and Estimates Chart

Earnings by Quarter for Allscripts (NASDAQ:MDRX)

Allscripts (NASDAQ:MDRX) Earnings Estimates

2018 EPS Consensus Estimate: $0.57
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.11$0.13$0.12
Q2 20182$0.13$0.14$0.14
Q3 20182$0.15$0.15$0.15
Q4 20182$0.16$0.16$0.16

Allscripts (NASDAQ MDRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018$0.17N/AView Earnings Details
2/15/2018Q4 2017$0.18$0.18$524.05 million$547.00 millionViewListenView Earnings Details
11/2/2017Q3 2017$0.12$0.12$429.94 million$451.20 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.15$0.11$424.94 million$426.10 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.1530$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
11/8/2010Q3 2010$0.16$0.17ViewN/AView Earnings Details
7/20/2010Q2 2010$0.15$0.15ViewN/AView Earnings Details
4/7/2010Q1 2010$0.14$0.14ViewN/AView Earnings Details
1/10/2010Q4 2009$0.13$0.14ViewN/AView Earnings Details
9/29/2009Q3 2009$0.13$0.14ViewN/AView Earnings Details
7/20/2009Q2 2009$0.14$0.15ViewN/AView Earnings Details
4/2/2009Q1 2009$0.12$0.14ViewN/AView Earnings Details
1/8/2009Q4 2008$0.12$0.14ViewN/AView Earnings Details
10/23/2008Q3 2008$0.13$0.13ViewN/AView Earnings Details
8/5/2008Q2 2008$0.09$0.11ViewN/AView Earnings Details
4/30/2008Q1 2008$0.10$0.07ViewN/AView Earnings Details
2/13/2008Q4 2007$0.12$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Allscripts (NASDAQ:MDRX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Allscripts (NASDAQ MDRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.10%
Insider Trading History for Allscripts (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts (NASDAQ:MDRX)

Allscripts (NASDAQ MDRX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2018Richard J PoultonPresidentSell15,000$13.53$202,950.00505,920View SEC Filing  
3/14/2018Brian FarleyEVPSell5,000$13.73$68,650.00240,672View SEC Filing  
12/15/2017Richard J PoultonPresidentSell15,000$14.26$213,900.001,351,773View SEC Filing  
12/14/2017Brian FarleyEVPSell5,000$14.35$71,750.00191,607View SEC Filing  
12/1/2017James HewittSVPSell36,796$14.11$519,191.56181,766View SEC Filing  
9/15/2017Richard J. PoultonPresidentSell15,000$13.56$203,400.00View SEC Filing  
9/14/2017Brian FarleyEVPSell5,000$13.52$67,600.00196,607View SEC Filing  
9/14/2017Paul BlackCEOSell15,000$13.52$202,800.00View SEC Filing  
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00412,488View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00217,861View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00158,104View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.001,177,009View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00210,887View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00175,604View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.001,197,329View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00343,813View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00217,887View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00228,104View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.001,224,939View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00359,064View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.0032,560View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.0033,655View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.0024,225View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Allscripts (NASDAQ MDRX) News Headlines

Source:
DateHeadline
JPMorgan Assumes Allscripts (MDRX) at OverweightJPMorgan Assumes Allscripts (MDRX) at Overweight
www.streetinsider.com - April 24 at 8:28 AM
Technical Perspectives on Application Software Stocks -- 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYSTechnical Perspectives on Application Software Stocks -- 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYS
www.prnewswire.com - April 23 at 8:24 AM
 Analysts Expect Allscripts (MDRX) Will Announce Quarterly Sales of $532.66 Million Analysts Expect Allscripts (MDRX) Will Announce Quarterly Sales of $532.66 Million
www.americanbankingnews.com - April 19 at 4:57 AM
Zacks: Brokerages Anticipate Allscripts (MDRX) Will Post Earnings of $0.17 Per ShareZacks: Brokerages Anticipate Allscripts (MDRX) Will Post Earnings of $0.17 Per Share
www.americanbankingnews.com - April 17 at 1:12 AM
Allscripts (MDRX) Given Consensus Recommendation of "Hold" by AnalystsAllscripts (MDRX) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - April 12 at 8:12 PM
DIGITAL HEALTH BRIEFING: Google, AMA launch interoperability challenge — Doctor On Demand rolls out location ...DIGITAL HEALTH BRIEFING: Google, AMA launch interoperability challenge — Doctor On Demand rolls out location ...
www.businessinsider.com - April 12 at 8:56 AM
Short Interest in Allscripts (MDRX) Increases By 29.0%Short Interest in Allscripts (MDRX) Increases By 29.0%
www.americanbankingnews.com - April 12 at 2:17 AM
Allscripts (MDRX) Lifted to "Hold" at Zacks Investment ResearchAllscripts (MDRX) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 11 at 6:45 PM
Allscripts to release first-quarter 2018 financial results May 3Allscripts to release first-quarter 2018 financial results May 3
finance.yahoo.com - April 9 at 5:11 PM
Dougherty & Co Reiterates Buy Rating for Allscripts (MDRX)Dougherty & Co Reiterates Buy Rating for Allscripts (MDRX)
www.americanbankingnews.com - April 8 at 10:08 AM
Cantor Fitzgerald Reiterates Buy Rating for Allscripts (MDRX)Cantor Fitzgerald Reiterates Buy Rating for Allscripts (MDRX)
www.americanbankingnews.com - April 5 at 1:57 PM
Allscripts (MDRX) Downgraded by BidaskClubAllscripts (MDRX) Downgraded by BidaskClub
www.americanbankingnews.com - April 5 at 12:30 AM
Allscripts (MDRX) Downgraded by TheStreetAllscripts (MDRX) Downgraded by TheStreet
www.americanbankingnews.com - April 4 at 12:49 PM
ValuEngine Lowers Allscripts (MDRX) to SellValuEngine Lowers Allscripts (MDRX) to Sell
www.americanbankingnews.com - April 3 at 11:31 PM
Global Big Data in Healthcare Market 2017-2025 Featuring Key Players - McKesson, Allscripts, Epic Systems, Cerner ...Global Big Data in Healthcare Market 2017-2025 Featuring Key Players - McKesson, Allscripts, Epic Systems, Cerner ...
globenewswire.com - April 3 at 5:24 PM
Stratice Healthcare achieves Certification through the Allscripts Developer Program for eOrdersPlusStratice Healthcare achieves Certification through the Allscripts Developer Program for eOrdersPlus
globenewswire.com - April 2 at 5:17 PM
Hyland completes acquisition of OneContent from AllscriptsHyland completes acquisition of OneContent from Allscripts
www.prnewswire.com - April 2 at 5:17 PM
Allscripts closes OneContent business to Hyland Software, Inc.Allscripts closes OneContent business to Hyland Software, Inc.
finance.yahoo.com - April 2 at 5:16 PM
Allscripts (MDRX) Expected to Post Quarterly Sales of $533.09 MillionAllscripts (MDRX) Expected to Post Quarterly Sales of $533.09 Million
www.americanbankingnews.com - April 2 at 4:58 AM
Allscripts Healthcare Solutions Inc (MDRX) Expected to Post Earnings of $0.17 Per ShareAllscripts Healthcare Solutions Inc (MDRX) Expected to Post Earnings of $0.17 Per Share
www.americanbankingnews.com - March 31 at 5:21 AM
Allscripts Healthcare Solutions (MDRX) Stock Rating Lowered by SunTrust BanksAllscripts Healthcare Solutions (MDRX) Stock Rating Lowered by SunTrust Banks
www.americanbankingnews.com - March 28 at 3:14 PM
Free Research Report as Allscripts’ Quarterly Revenues Jumped 22% and Adjusted EPS Surged 29%Free Research Report as Allscripts’ Quarterly Revenues Jumped 22% and Adjusted EPS Surged 29%
finance.yahoo.com - March 28 at 8:41 AM
Allscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at Bank of AmericaAllscripts Healthcare Solutions (MDRX) Earns Buy Rating from Analysts at Bank of America
www.americanbankingnews.com - March 24 at 9:28 PM
RBC Sees 4 Software Stocks as Potential Takeover Candidates - 24/7 Wall St.RBC Sees 4 Software Stocks as Potential Takeover Candidates - 24/7 Wall St.
247wallst.com - March 21 at 9:10 AM
Oversold Conditions For Allscripts Healthcare Solutions (MDRX) - NasdaqOversold Conditions For Allscripts Healthcare Solutions (MDRX) - Nasdaq
www.nasdaq.com - March 21 at 9:10 AM
Why Is Allscripts (MDRX) Down 11.3% Since its Last Earnings Report? - NasdaqWhy Is Allscripts (MDRX) Down 11.3% Since its Last Earnings Report? - Nasdaq
www.nasdaq.com - March 19 at 8:34 AM
Why Is Allscripts (MDRX) Down 11.3% Since its Last Earnings Report?Why Is Allscripts (MDRX) Down 11.3% Since its Last Earnings Report?
finance.yahoo.com - March 19 at 8:34 AM
Allscripts Healthcare Solutions Inc (MDRX) Receives Average Recommendation of "Buy" from AnalystsAllscripts Healthcare Solutions Inc (MDRX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 18 at 7:42 PM
Is the Tax Repeal Only Glitter and No Gold for MedTech?Is the Tax Repeal Only Glitter and No Gold for MedTech?
finance.yahoo.com - March 16 at 6:18 PM
Zacks: Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Announce Quarterly Sales of $533.39 MillionZacks: Analysts Expect Allscripts Healthcare Solutions Inc (MDRX) Will Announce Quarterly Sales of $533.39 Million
www.americanbankingnews.com - March 16 at 7:32 AM
Allscripts Healthcare Solutions Inc (MDRX) President Sells $202,950.00 in StockAllscripts Healthcare Solutions Inc (MDRX) President Sells $202,950.00 in Stock
www.americanbankingnews.com - March 15 at 8:42 PM
Insider Selling: Allscripts Healthcare Solutions Inc (MDRX) EVP Sells 5,000 Shares of StockInsider Selling: Allscripts Healthcare Solutions Inc (MDRX) EVP Sells 5,000 Shares of Stock
www.americanbankingnews.com - March 15 at 8:28 PM
Allscripts Healthcare Solutions (MDRX) Stock Rating Lowered by BidaskClubAllscripts Healthcare Solutions (MDRX) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - March 14 at 6:38 PM
Hyland Software, Inc. -- Moodys affirms Hylands B2 CFR after debt-funded acquisitionHyland Software, Inc. -- Moody's affirms Hyland's B2 CFR after debt-funded acquisition
finance.yahoo.com - March 8 at 6:24 PM
Allscripts (MDRX) Launches Avenel to Revamp EHR PlatformAllscripts (MDRX) Launches Avenel to Revamp EHR Platform
finance.yahoo.com - March 7 at 8:31 AM
Allscripts Healthcare Solutions (MDRX) "Buy" Rating Reiterated at Cantor FitzgeraldAllscripts Healthcare Solutions' (MDRX) "Buy" Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - March 6 at 3:28 PM
Allscripts Healthcare Solutions Inc (MDRX) Shares Sold by Tamarack Advisers LPAllscripts Healthcare Solutions Inc (MDRX) Shares Sold by Tamarack Advisers LP
www.americanbankingnews.com - March 6 at 10:30 AM
Allscripts, Lyft partner on health care transportation - MarketWatchAllscripts, Lyft partner on health care transportation - MarketWatch
www.marketwatch.com - March 6 at 8:28 AM
Allscripts launches industrys first machine learning EHR - GlobeNewswire (press release)Allscripts launches industry's first machine learning EHR - GlobeNewswire (press release)
www.globenewswire.com - March 6 at 8:28 AM
Allscripts launches industry’s first machine learning EHRAllscripts launches industry’s first machine learning EHR
finance.yahoo.com - March 6 at 8:28 AM
California Public Employees Retirement System Boosts Stake in Allscripts Healthcare Solutions Inc (MDRX)California Public Employees Retirement System Boosts Stake in Allscripts Healthcare Solutions Inc (MDRX)
www.americanbankingnews.com - March 6 at 5:26 AM
Lyft Looks to Pioneer the Future of Ride-HailingLyft Looks to Pioneer the Future of Ride-Hailing
www.msn.com - March 5 at 5:42 PM
Lyft and Allscripts want to make it easier to get people to the doctor's officeLyft and Allscripts want to make it easier to get people to the doctor's office
finance.yahoo.com - March 5 at 5:42 PM
Allscripts, Lyft partner on health care transportationAllscripts, Lyft partner on health care transportation
finance.yahoo.com - March 5 at 5:42 PM
Millrace Asset Group Inc. Has $1.70 Million Stake in Allscripts Healthcare Solutions Inc (MDRX)Millrace Asset Group Inc. Has $1.70 Million Stake in Allscripts Healthcare Solutions Inc (MDRX)
www.americanbankingnews.com - March 5 at 12:54 PM
Martingale Asset Management L P Grows Stake in Allscripts Healthcare Solutions Inc (MDRX)Martingale Asset Management L P Grows Stake in Allscripts Healthcare Solutions Inc (MDRX)
www.americanbankingnews.com - March 5 at 10:14 AM
Allscripts and Lyft partner to eliminate transportation barriers to healthcare - GlobeNewswire (press release)Allscripts and Lyft partner to eliminate transportation barriers to healthcare - GlobeNewswire (press release)
globenewswire.com - March 5 at 8:33 AM
[$$] Patients Missing Doctor Visits Get Helping Hand[$$] Patients Missing Doctor Visits Get Helping Hand
finance.yahoo.com - March 5 at 8:33 AM
Lyft and Allscripts want to make it easier to get people to the doctors officeLyft and Allscripts want to make it easier to get people to the doctor's office
finance.yahoo.com - March 5 at 8:33 AM
Allscripts and Lyft partner to eliminate transportation barriers to healthcareAllscripts and Lyft partner to eliminate transportation barriers to healthcare
finance.yahoo.com - March 5 at 8:33 AM

SEC Filings

Allscripts (NASDAQ:MDRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Allscripts (NASDAQ:MDRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Allscripts (NASDAQ MDRX) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.